Activation of KCNQ Channels Prevents Paclitaxel-Induced Peripheral Neuropathy and Associated Neuropathic Pain

Keyphrases

• Neuropathic Pain 100%
• Paclitaxel-induced Peripheral Neuropathy 100%
• KCNQ Channels 100%
• Paclitaxel 44%
• Retigabine 44%
• Kv7 Channels 44%
• Primary Sensory Neurons 22%
• Excitability 22%
• Cancer Patients 11%
• Quality of Life 11%
• Quantitative PCR 11%
• Nociceptor 11%
• Western Blotting 11%
• High Risk 11%
• Acute Pain 11%
• Effective Strategies 11%
• Expression Level 11%
• Daily Activities 11%
• Breast Cancer Cells 11%
• Anticonvulsant 11%
• Chemosensitivity 11%
• Behavioral Evidence 11%
• Repurposing 11%
• Serious Adverse Effects 11%

Neuroscience

• Neuropathic Pain 100%
• Paclitaxel 100%
• Potassium Channel KCNQ 100%
• Neuropathy 100%
• Retigabine 30%
• Sensory Neuron 15%
• Excitability 15%
• Nociceptor 7%
• Adverse Effect 7%
• Western Blotting 7%
• Reverse Transcription Polymerase Chain Reaction 7%
• Anticonvulsant 7%

Pharmacology, Toxicology and Pharmaceutical Science

• Neuropathic Pain 100%
• Neuropathy 100%
• Paclitaxel 100%
• Potassium Channel KCNQ 100%
• Retigabine 30%
• Malignant Neoplasm 7%
• Adverse Event 7%
• Western Blot 7%
• Pain 7%
• Breast Cancer 7%
• Anticonvulsive Agent 7%
• Channel Opener 7%